Principal
Aranmore Pharma Consulting
Lawrenceville, New Jersey
Griff Humphreys, PhD is currently principal with Aranmore Pharma Consulting. Prior to that he spent 26 years at Bristol-Myers Squibb Pharmaceutical Company in various leadership roles within the DMPK functional area. He received his graduate training at the University of Virginia in chemistry and
completed a post-doctoral fellowship at Vanderbilt University Center in Molecular Toxicology. His interests include predictive metabolism and toxicology models and other aspects of candidate optimization and characterization. He has co-authored over 130 refereed manuscripts and numerous reviews. Griff is a member of the ISSX and the ACS Chemical Toxicology Division (TOXI). He is on the Editorial Advisory Boards of Drug Metabolism and Disposition and serves as reviewer for multiple additional journals. He served on the Executive Committee of TOXI from 2008-2017 and was TOXI Program Chair for the 2013-2014 National meetings. Griff was on the ISSX Council from 2016-2019 and was a member of the Meeting Organizing Committee for the 22nd NA ISSX Meeting. He was Meeting Chair for the 2019 Drug Metabolism Gordon Research Conference.
Disclosure information not submitted.
Wednesday, October 19, 2022
11:30 AM – 12:30 PM ET